Click the button below to contact us or submit your feedback about this product.
This product is an unconjugated Recombinant anti-Adalimumab Monoclonal Antibody (NGE09-TT) gernerated by phage display technology from the human Cells. This antibody can be used for ELISA.
Please feel free to contact us for a quote and further discussion with our scientists. Datasheets
specifications |
|
|---|---|
| Antibody Isotype | IgE |
| Clone | NGE09-TT |
| Applications | ELISA |
| Target | Adalimumab |
| Host | Human Cells |
| Clonality | Monoclonal |
| Antibody Type | Primary antibody |
| Species Reactivity | Human |
| Immunogen | Adalimumab |
| Format | Liquid |
| Buffer | PBS |
| Storage | Store at 4°C for short-term and -20°C for long-term. Avoid repeated freeze-thaw cycles. |
Target Information |
|
|---|---|
| Target Name | Adalimumab |
| Alternative Names | Humira; anti-TNFα monoclonal antibody; adalimumab-adaz; adalimumab-adbm; adalimumab-afzb; adalimumab-atto; adalimumab-bwwd |
| Related Disease | Autoimmune diseases |
| Target Overview | Adalimumab, also known as Humira®, is the first fully human anti-TNFα monoclonal antibody (IgG1/kappa) that was approved for the treatment of ankylosing spondylitis, Crohn's disease, psoriasis and several forms of arthritis. The antibody was produced by phage display which is specific for TNFα, and acts as a TNF inhibitor to block the activation of TNF receptors by TNFα. Common side effects include upper respiratory tract infection, injection site pain, rash and headache. |
Click the button below to contact us or submit your feedback about this product.
KINDLY NOTE
!! For Research Use Only. Our products and services are NOT intended for diagnostic or therapeutic applications.
!! Custom antibodies beyond the list can be tailored flexibly. Please directly Email us your specific demands.
© 2024 Creative Biolabs All Rights Reserved
Datasheet